DAIC

JUNE 4, 2024

Penn Presbyterian Medical Center Becomes First Hospital in the Northeast to Adopt Advanced Robotic Technology for Heart Treatment 5. Late-breaking Clinical Trial Results from FARADISE, admIRE Study and Advent Trial at Heart Rhythm 2024 Highlight Pulsed Field Ablation Developments for Atrial Fibrillation Treatment 8.

Preserved Ejection Fraction 105

Preserved Ejection Fraction Peripheral Arterial Disease Heart Failure Atrial Fibrillation 105

HeartRhythm

APRIL 30, 2024

Pulmonary vein (PV) isolation is the cornerstone of radiofrequency (RF) ablation for atrial fibrillation (AF). PV reconnection is the most common cause of recurrent AF following an ablation procedure. Additionally, the relationship between impedance drop during ablation lesion delivery and PV ostial WT is not well understood.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Pulmonary Technology 40

HeartRhythm

APRIL 30, 2024

Pulsed field ablation (PFA) has recently been introduced as a novel ablation technology for pulmonary vein isolation (PVI) in patients with atrial fibrillation (AF). High rates of acute PVI have been observed based on electrograms of the PFA device only.

Ablation 40

Ablation Pulmonary Atrial Fibrillation Technology 40

HeartRhythm

AUGUST 21, 2024

No data have been reported on cooling characteristics and the impact of variant pulmonary vein (PV) anatomy on atrial fibrillation (AF) recurrences after POLARx cryoballoon (CB) ablation.

Anatomy 40

Anatomy Atrial Fibrillation Pulmonary Ablation 40

HeartRhythm

APRIL 30, 2024

Cryoballoon (CB) ablation is the mainstay of single-shot pulmonary vein isolation (PVI). However, these two technologies have not been compared. A radiofrequency balloon (RFB) catheter has recently emerged as an alternative.

Pulmonary 40

Pulmonary Ablation Technology Outcomes 40

DAIC

JULY 17, 2024

a company focused on cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases announced that the Unites States Patent Office has granted Patent No: 12,036,371 titled “Method of Accessing the Left Atrium with a Multi-Directional Steerable Catheter,” with a patent term that will expire in 2035.

Myocardial Infarction 105

Myocardial Infarction Atrial Fibrillation Technology Angina 105

HeartRhythm

APRIL 30, 2024

Non-thermal pulsed field ablation (PFA) is an novel technology to perform pulmonary vein isolation (PVI) for atrial fibrillation (AF). Different PFA systems are available, but no comparative data exist.

Atrial Fibrillation 40

Atrial Fibrillation Pulmonary Ablation Technology 40

DAIC

DECEMBER 26, 2023

a company primarily focused on leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation (nsPFA) technology for the treatment of atrial fibrillation, announced the completion of the first five procedures in its first-in-human feasibility study with its novel CellFX nsPFA cardiac catheter.

Ablation 59

Ablation Atrial Fibrillation Technology Cardiothoracic 59

Journal of Cardiovascular Electrophysiology

MARCH 3, 2024

Abstract Introduction Through systematic scientific rigor, the CLOSE guided workflow was developed and has been shown to improve pulmonary vein isolation durability. However, this technique was developed at a time when using power-controlled ablation catheters with conventional power ranges was the norm.

Ablation 40

Ablation Pulmonary Technology Outcomes 40

Journal of Cardiothoracic Surgery

JANUARY 22, 2025

Pulmonary vein isolation (PVI) with cryoballoon (CB) ablation technology is widely used to treat drug-resistant atrial fibrillation (AF). During CB ablation, there is a possibility of forming an ice cap of con.

Ablation 40

Ablation Atrial Fibrillation Technology Pulmonary 40

HeartRhythm

APRIL 30, 2024

The 1st generation HeartLight laser balloon (LB) ablation is highly effective in achieving pulmonary vein isolation (PVI), and the safety and 12-month efficacy are comparable with paroxysmal atrial fibrillation (PAF) ablation technologies.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Technology Pulmonary 40

HeartRhythm

APRIL 30, 2024

No single-shot pulsed field ablation (PFA) technology for pulmonary vein (PV) isolation can directly verify tissue contact.

Ablation 40

Ablation Technology Pulmonary 40

Journal of Cardiovascular Electrophysiology

DECEMBER 7, 2023

Abstract Background The newly introduced nonthermal pulsed field ablation (PFA) is a promising technology to achieve fast pulmonary vein isolation (PVI) with high acute success rates and good safety features. Data comparing PFA to VHPSD-PVI is lacking. One clinically nonsignificant PV stenosis occurred in the VHPSD group.

Ablation 40

Ablation Pulmonary Arrhythmia Atrial Fibrillation 40

HeartRhythm

APRIL 30, 2024

Pulsed field ablation (PFA) has recently been introduced as a novel routine ablation technology for paroxysmal atrial fibrillation (AF). It is also used as off-label therapy for persistent AF.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Technology Pulmonary 40

HeartRhythm

APRIL 30, 2024

We have employed digital twin technology to perform extra pulmonary vein (PV) ablation in patients with non-paroxysmal atrial fibrillation (AF). We reported that high dominant frequency (DF) site ablation improved rhythm outcomes, but high maximal slope of action potential restitution curve (Smax) site ablation did not.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Technology Pulmonary 40

HeartRhythm

APRIL 30, 2024

Pulsed-field ablation (PFA) is novel ablative technology utilizing high-voltage, ultra-short electrical pulses to induce electroporation and cell apoptosis. The PFA dose needed to induce chronic lesion formation requires further assessment.

Ablation 40

Ablation Technology Pulmonary 40

Journal of Cardiovascular Electrophysiology

DECEMBER 17, 2023

This study investigated myocardial injury and inflammation following pulmonary vein isolation using (1) Standard radiofrequency ablation, (2) very high-power short-duration (vHPSD)-70W, (3) vHPSD-90W, and (4) pulsed-field ablation (PFA). Results Baseline characteristics were well-balanced between groups (age 63.1 ± 10.3

Ablation 40

Ablation Atrial Fibrillation Technology Pulmonary 40

HeartRhythm

APRIL 30, 2024

Pulsed-field ablation (PFA) is becoming increasingly relevant in the field of electrophysiology. Besides single-shot PFA devices for pulmonary vein isolation (PVI), point-by-point PFA is also gaining importance due to many possible applications. Data on the use is sparse, especially for atrial tachycardia (AT).

Tachycardia 40

Tachycardia Ablation Electrophysiology Technology 40

Journal of Cardiovascular Electrophysiology

FEBRUARY 20, 2025

ABSTRACT Introduction The extensive use of pulsed field ablation (PFA) in clinical settings has unveiled new evidence suggesting potential involvement in red blood cell structural impairment resulting in hemolysis and potential acute kidney injury (AKI).

Biomarkers 40

Biomarkers Pulmonary Technology Ablation 40

Journal of Cardiovascular Electrophysiology

DECEMBER 7, 2023

Abstract Introduction Catheter ablation of atrial fibrillation (AF) has emerged as the most effective therapy. However, rare anatomical abnormalities such as situs inversus totalis, dextrocardia, or interrupted inferior vena cava can make ablation challenging.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Pacemaker Technology 40

Journal of Cardiovascular Electrophysiology

NOVEMBER 6, 2024

Characteristics of acute insufficient lesions during vHPSD ablation were analyzed in the retrospective phase. Based on these data, an optimized approach combining both vHPSD ablation and AI-guided ablation was prospectively tested, resulting in an approximately 90% first-pass PVI rate. 0001) with shorter ablation time ( p =.04).

Ablation 40

Ablation Atrial Fibrillation Technology Pulmonary 40

Journal of Cardiovascular Electrophysiology

JANUARY 10, 2024

Abstract Introduction Despite advanced ablation strategies and major technological improvements, treatment of persistent atrial fibrillation (AF) remains challenging and the underlying pathophysiology is not fully understood. Randomized studies are necessary to evaluate long-term efficacy of dispersion-guided ablation using AI.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Outpatient Arrhythmia 40

HeartRhythm

APRIL 30, 2024

Left atrial (LA) low voltage area (LVA) burden correlates with AF recurrence risk post pulmonary vein isolation. Adjunctive ablation targeting LVAs, has been reported to improve outcomes. Omnipolar technology (OT) overcomes many limitations of BiV mapping, however there is little data on equivalent OT thresholds.

Technology 40

Technology Pulmonary Ablation Outcomes 40

DAIC

MARCH 27, 2025

1,2 People living with AFib face an increased risk of stroke, heart failure and death, and many rely on cardiac ablation to treat the condition effectively. The trial showed the Volt PFA System achieved pulmonary vein isolation (PVI) the method of destroying tissue causing a patient's AFib in 99.1% Procedural flexibility.

Ablation 52

Ablation AFIB Atrial Fibrillation Electrophysiology 52

DAIC

FEBRUARY 14, 2025

In particular, the study showed superiority in the percentage of patients that achieved freedom from atrial fibrillation (AF) with or without anti-arrhythmic drugs at 12 months after a tailored cardiac ablation guided by AI in combination with PVI when compared to PVI alone. tim.hodson Fri, 02/14/2025 - 09:57 Feb.

Atrial Fibrillation 52

Atrial Fibrillation Ablation Technology Pulmonary 52

DAIC

MAY 18, 2024

During its Annual Conference, HRS 2024, the Heart Rhythm Society (HRS) announced findings from three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), a nonthermal ablation treatment for patients with atrial fibrillation (AF). See full findings from the FARADISE, admIRE Study, and Advent Trial here.

Heart Rhythm 105

Heart Rhythm Atrial Fibrillation Ablation Quality of Life 105

DAIC

DECEMBER 14, 2023

This is the first PFA technology to receive FDA approval and follows the recent European CE (Conformité Européenne) Mark of the PulseSelect PFA system in November. In my clinical experience with the catheter, it was designed for AF ablation procedures.

Atrial Fibrillation 105

Atrial Fibrillation Ablation Technology Heart Failure 105

DAIC

JULY 24, 2024

Volta Medical has announced it has entered into a Joint Development Agreement with GE Healthcare to enhance arrhythmia procedures with artificial intelligence (AI)-driven electrophysiology technologies. Our mission to combat complex heart rhythm diseases relies on optimizing interoperability.

Atrial Fibrillation 105

Atrial Fibrillation AFIB Ablation Technology 105

DAIC

MARCH 5, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech , today announced European CE mark approval of the VARIPULSE Platform for the treatment of symptomatic drug refractory recurrent paroxysmal atrial fibrillation ( AF ) using pulsed field ablation (PFA). iii] The study reported a low fluoroscopy time of 7.8

Ablation 59

Ablation Atrial Fibrillation Atrial Flutter Pulmonary 59

HeartRhythm

JULY 1, 2024

One of the most significant recent advances in developing new technologies for the interventional treatment of atrial fibrillation (AF) has been the introduction of pulsed field ablation (PFA).1

Atrial Fibrillation 40

Atrial Fibrillation Ablation Pulmonary Technology 40

HeartRhythm

APRIL 30, 2024

Pulsed field ablation (PFA) is an emerging technology that applies high voltage electrical pulses to cardiac tissue selectively and induces cell death through predominately non-thermal irreversible electroporation.

Ablation 40

Ablation Arrhythmia Technology Pulmonary 40

DAIC

JUNE 19, 2024

By the 1960s, advances in technology and medical research led to the emergence of automated ECG interpretation (AEI), based on physician-developed rules of classification. By 1909 ECGs were being used to diagnose cases of arrhythmia; by 1910 to diagnose indicators of a heart attack.

AFIB 105

AFIB Reimbursement Research Atrial Fibrillation 105

Journal of Cardiovascular Electrophysiology

DECEMBER 7, 2023

Abstract Introduction Pulsed field ablation (PFA) is a new ablation technology for atrial fibrillation (AF). Data regarding early recurrences of atrial tachyarrhythmia (ERAT) after PFA-pulmonary vein isolation (PVI) are sparse. Methods Consecutive patients with symptomatic AF were enrolled to undergo PFA-PVI.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Document Tachycardia 40

Journal of Cardiovascular Electrophysiology

MARCH 19, 2025

ABSTRACT Introduction Pulmonary vein isolation (PVI) using a cryoballoon is well-established for the treatment of paroxysmal atrial fibrillation (PAF). Compared to other available technologies, the usage of a stable, low-pressure cryoballoon (POLARx, Boston Scientific) has demonstrated lower nadir temperatures and longer thawing times.

Atrial Fibrillation 40

Atrial Fibrillation Myocardial Infarction Pulmonary Technology 40

DAIC

JULY 8, 2024

PFA is the latest ablation modality approved by the Food and Drug Administration that can be used to restore a regular heartbeat. Given the relative novelty of pulsed field ablation, these are important safety outcomes.” Patients with AF can undergo a catheter procedure, called catheter ablation, to treat this abnormal heart rhythm.

Atrial Fibrillation 105

Atrial Fibrillation Ablation Pulmonary Heart Rhythm 105

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Published Research kschukar Thu, 04/20/2023 - 11:12 Recently published (2016 – present) manuscripts utilizing STS data: Adult Cardiac Surgery, General Thoracic Surgery, Congenital Heart Surgery, and Intermacs/Pedimacs.

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

CardiacWire

NOVEMBER 6, 2024

Cortex gives Boston Scientific a new mapping technology that detects AFib signs and triggers outside of the pulmonary veins, and can help EP teams develop ablation strategies for more complex AFib cases. for an undisclosed sum.

AFIB 105

AFIB Electrophysiology Ablation Technology 105